Skip to content

Electrical stimulation of the centromedian thalamic nucleus for treatment of refractory epilepsy

Electrical stimulation of the centromedian thalamic nucleus for treatment of refractory epilepsy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065280
Enrollment
Unknown
Registered
2022-11-01
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory epilepsy

Interventions

1: stimulation of the centromedian thalamic nucleus

Sponsors

Xuanwu Hospital,Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 10-60 years; 2. Conforming to the diagnostic criteria of drug refractory epilepsy (patients who have been treated with regular drugs for 2 years but have no effect); 3. Seizure type: comprehensive or secondary comprehensive epilepsy; 4.electrodes to guide further treatment; 5. Agree to participate in the study and sign the informed consent form; We are willing to abide by the relevant regulations of the test program, and come to review and conduct relevant inspections within the specified time limit.

Exclusion criteria

Exclusion criteria: 1. Having brain tumor or other degenerative diseases of central nervous system; 2. Those who have mental illness and can not be examined as required; 3. There are structural changes in thalamus; 4. Severe cognitive impairment, IQ<50; 5. Pregnant women or high risk of bleeding; 6. Other serious physical diseases or severe abnormal liver and kidney functions in laboratory; 7. Patients who cannot complete the electrical stimulation test due to objective factors; 8. Abnormal laboratory tests during screening period, or other laboratory tests considered clinically significant;

Design outcomes

Primary

MeasureTime frame
Seizure frequency;Epilepsy type;

Countries

China

Contacts

Public ContactYu Tao

Xuanwu Hospital,Capital Medical University

yutaoly@sina.com+86 13391769290

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026